Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Raltegravir, ATC J05AJ01

AOK Bayern - Die Gesundheitskasse · Germany government procurement

GlobalGov surfaces government procurement from around the world, including the markets your competitors overlook.

August 03, 2028
Response Due
Active
Status

Opportunity Overview

Siehe kurze Beschreibung ACHTUNG: Die Vertragsunterlagen sind zwingend über den Kommunikationsbereich im Vergabeportal www.dtvp.de einzureichen und keinesfalls über den Angebotsbereich! BITTE BEACHTEN SIE: Die FRIST für einen Vertragsschluss zum nächsten Monatsersten endet jeweils am DRITTEN des Vormonats.

This Germany Pharmaceuticals opportunity is one most of your competitors will never see.

How to bid: GlobalGov tracks this tender; it does not accept bids. Submit your response through the issuing agency’s official notice.

Your competitors are watching the same crowded contracts everyone else is. Track this opportunity and every one like it worldwide, set deadline alerts, and win where they aren’t. Free for 14 days, no card.

Start a free GlobalGov account

Solicitation Details

Issuing agencyAOK Bayern - Die Gesundheitskasse
CountryGermany
CategoryPharmaceuticals
PublishedAugust 13, 2026
Procurement stageRequest for Proposal (RFP)
Response dueAugust 03, 2028
StatusOpen — accepting responses
Original languageGerman — members read it in their own language
Official sourceView original notice
Last verifiedOctober 11, 2026

Source: Tenders Electronic Daily (TED), © European Union. Notice content reused under Commission Decision 2011/833/EU; editorial content licensed CC BY 4.0. GlobalGov is not affiliated with the European Union.

Related Opportunities in Germany

Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Brimonidin (ausschl. DaFo Einzeldosen), ATC S01EA05 f. d. Z. 01.10.26 - 30.09.28 (zzgl. V.-Option 1x12 Mon)
Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Dapagliflozin, ATC A10BK01 für die Zeit 01.10.2026 - 30.09.2028
Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge zum Wirkstoff Trastuzumab, nur s.c.-Darreichungsform, ATC L01FD01
Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge zum Wirkstoff Nevirapin, ATC J05AG01
Germany – Pharmaceutical products – Open-House-Rabattverträge 2025-08
Germany – Pharmaceutical products – Open-House-Rabattverträge 2026-14
Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Teduglutid (ATC-Code nach WHO: A16AX08)
Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge zum Wirkstoff Sulfasalazin, ATC M01CX02

See every Germany Pharmaceuticals opportunity your competition is missing. Free for 14 days.

Get real-time alerts, competitive intelligence, and deadline tracking for this and every market worldwide.

Start Free Trial — No Card Required

Free 14-day trial · no card required

See who is already competing here →

Get a free Germany Pharmaceuticals intelligence report in your inbox

A personalized report on Germany Pharmaceuticals opportunities, emailed in 5-10 minutes. One per month, no account needed.